To Evaluate the Efficacy of Capsimax on Metabolic Rate
Status
Completed
Conditions
Metabolism
Treatments
Other: Micro Crystalline Cellulose
Other: Capsimax
Details and patient eligibility
About
Capsimax™ is a proprietary Capsicum Extract that employs Beadlet Technology. In the previous study it has been used to investigate its effect in reducing body fat/weight and increase metabolic rate. In this study, Capsimax™ will be used to assess effect on Resting Energy Expenditure (REE) using Indirect Calorimetry.
Enrollment
44 patients
Sex
All
Ages
18 to 55 years old
Volunteers
Accepts Healthy Volunteers
Inclusion criteria
- Healthy, adult, male/female participants with age ≥ 18 ≤ 55 years.
- A Body Mass Index (BMI) between 18.5 to 29.9 kg/m2.
- Fasting blood sugar ≤ 100 mg/dl
- Hemoglobin: Males ≥ 11 g/dl and Females ≥ 10 g/dl
- BP < 140/90 mmHg
Exclusion criteria
- Post-menopausal females
- History of hypo/ hyperthyroidism.
- History of significant neurological or psychiatric condition such as seizures, depression, or insomnia.
Trial design
Primary purpose
Other
Allocation
Randomized
Interventional model
Crossover Assignment
Masking
Quadruple Blind
44 participants in 2 patient groups, including a placebo group
Capsimax
Active Comparator group
Treatment:
Other: Micro Crystalline Cellulose
Other: Capsimax
Placebo
Placebo Comparator group
Treatment:
Other: Micro Crystalline Cellulose
Other: Capsimax
Trial contacts and locations
1
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems